Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Anti-Hypertensive Drugs Market From 2025 to 2029?

In recent times, there has been a slight expansion in the market size of anti-hypertensive drugs. The market is projected to increase from $37.42 billion in 2024 to $38.03 billion in 2025, indicating a compound annual growth rate (CAGR) of 1.6%. Factors such as environmental and lifestyle changes, past market competitiveness, traditional treatment choices, economic scenarios, and previous global health trends have contributed to the growth during the historic period.

The market for anti-hypertensive drugs is predicted to witness a minor escalation in the coming years, reaching an estimated value of “$40.74 billion in 2029 accounting for a compound annual growth rate (CAGR) of 1.7%. This growth during the projected period can be associated with its cost-friendly nature and accessibility, upcoming therapeutic advancements, epidemiological changes, modifications in regulation and approvals, evolving aged population demographics, alterations in health care policies, and reimbursement changes. Key trends that will characterize the forecast period involve therapeutic advancements, shifts in epidemiology, changes in regulatory frameworks, health care policy modifications, and strides in diagnosis and monitoring methods.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2410&type=smp

What Elements Are Contributing To Growth In The Anti-Hypertensive Drugs Market?

The expansion of the anti-hypertensive drug market is largely fuelled by a sedentary lifestyle. Factors such as excessive consumption of fast food, a deficiency in proper and balanced nutrition, and an insufficient amount of sleep owing to erratic work timings, have all led to a surge in hypertension. Hypertension is a direct cause of around 45% of heart disease-related deaths and 51% of stroke-related deaths. After hypertension is diagnosed in a patient, it becomes essential for them to consume medication based on the degree of their condition. For instance, data released by the National Health Service, a government department in England, in May 2023, revealed that hypertension prevalence increases with age. It starts at 9% in adults between 16 to 44, and escalates to 60% among those aged 65 and above. Such trends ensure an ongoing demand for these drugs, making it a significant driver for market growth.

The anti-hypertensive drugs market covered in this report is segmented –

1) By Therapeutics: Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators

2) By Disease Source: Primary Hypertension, Secondary Hypertension

3) By End Users: Hospitals, Clinics, Homecare

Subsegments:

1) By Diuretics: Thiazide Diuretics, Loop Diuretics, Potassium-Sparing Diuretics

2) By Angiotensin Receptor Blockers (ARBs): Losartan, Valsartan, Irbesartan, Candesartan

3) By Angiotensin Converting Enzyme (ACE) Inhibitors: Enalapril, Lisinopril, Ramipril, Benazepril

4) By Beta Blockers: Metoprolol, Atenolol, Carvedilol, Bisoprolol

5) By Alpha Blockers: Doxazosin, Prazosin, Terazosin

6) By Calcium Channel Blockers: Amlodipine, Diltiazem, Verapamil, Nifedipine

7) By Renin Inhibitors: Aliskiren

8) By Vasodilators: Hydralazine, Minoxidil

What Trends Are Currently Influencing Growth In The Anti-Hypertensive Drugs Market?

Leading firms in the anti-hypertensive drugs market are concentrating on the development of innovative products, like Metoprolol Succinate Extended-Release Tablets, to gain a competitive advantage in the industry. These tablets work as anti-hypertensive medication for individuals with high blood pressure. For instance, Granules India Limited, a pharmaceutical manufacturing company based in India, introduced Metoprolol Succinate Extended-Release Tablets in June 2023. These tablets were approved by the US federal agency, the Food and Drug Administration (FDA). These tablets, specifically designed for hypertension treatment, aim to reduce blood pressure. They come in various strengths, ranging from 25mg to 200mg. Their constitution includes beta-blockers that slow the heart rate, decrease the heart’s workload, and consequently reduce blood pressure.

Who Are The Key Contributors To Growth In The Anti-Hypertensive Drugs Market?

Major companies operating in the anti-hypertensive drugs market include Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbiVe Inc., Bayer AG, Novartis AG, Sanofi SA, Astra Zeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, C.H. Boehringer Sohn AG & Ko. KG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Daiichi Sankyo Company Limited, Fresenius Kabi AG, Sun Pharmaceuticals LLC, Cipla Limited, Dr. Reddy’s Laboratories, Hikma Pharmaceuticals PLC, Lupin Limited, Torrent Pharmaceuticals Ltd, Noden Pharma DAC, Actelion Pharmaceuticals Ltd.

https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report

Which Region Is Projected To Lead The Anti-Hypertensive Drugs Market By 2025?

North America was the largest region in the anti-hypertensive drugs market in 2024. The Middle East is expected to be the largest growing region in the global anti-hypertensive drugs market during the forecast period. The regions covered in the anti-hypertensive drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2410&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model